Poet Technologies Inc. (POET)

Price$7.76Cached quoteAs of 2026-09-04 16:23 UTC

AI: Overvalued

Price checkThe market price assumes a dramatic commercial leap that current revenue has not proven.

Using 172.6 million June shares, the observed quote values POET near $1.37 billion. Cash and short-term investments were $796.3 million and debt was $7.8 million, leaving roughly $583 million attributed to operations. That operating value equals about 340 times trailing revenue of $1.71 million. Illustratively, even valuing the business at ten dollars for each dollar of annual sales requires roughly $58 million of revenue, about 34 times the trailing amount. That expectation supports an Overvalued verdict.

Big pictureRevenue is growing, but losses and cash use still dwarf the business.

Second-quarter revenue rose 112% from a tiny prior-year base to $570,000, while the net loss remained $11.3 million. Operating activities used $12.2 million, and $3.1 million of equipment spending put quarterly free cash flow near negative $15.3 million. Free cash flow means cash left after operating and investment needs; here, none was left. Demand depends on rapid artificial-intelligence data-center spending and technology transitions, so delayed qualification could miss the current 800-gigabit and 1.6-terabit buying cycle.

Business strengthDeep cash reserves buy time, while customer orders offer conditional proof of demand.

The $796.3 million of cash and short-term investments against only $7.8 million of debt removes near-term financing pressure and can fund manufacturing expansion. Commercial evidence is emerging: Lumilens placed an initial $50 million order, and POET disclosed another $2.4 million order after quarter-end. However, Lumilens revenue depends on successful development, customer qualification and manufacturing scale-up. POET’s claimed cost and power advantages therefore remain unproven at volume, while the Marvell cancellation shows that individual customer relationships can reverse abruptly.

What could change the storySuccessful volume shipments could justify optimism, while delays and dilution would deepen the gap.

The bull case needs substantial qualification shipments, conversion of the $50 million Lumilens order into reported sales and progress toward management’s 30,000-unit 2026 goal. Capital use also matters: management planned about $50 million of equipment purchases and may pursue acquisitions. The bear case includes further delays or cancellations. Shares rose from 76.5 million at 2024 year-end to 172.6 million by June 2026. Financing, Lumilens and employee awards could add roughly 44 million more shares, although many warrants require higher prices or customer payments.

AI: News

Sales growth, losses persistThe latest quarter extended sales growth, but spending and losses remained far larger.

On August 13, POET reported sixth consecutive quarterly revenue growth: $570,000 was 13% above the first quarter and 112% above the prior-year quarter. The net loss narrowed to $11.3 million, but operating cash use increased to $12.2 million. A subsequent $2.4 million customer order added evidence of demand. Shares gained about 0.5% that day and 7.5% the next session; the timing suggests improved sentiment, but it does not establish that earnings alone caused the move.

Production ramp roadmapManagement set ambitious shipment and capacity targets that now need visible delivery.

The June 30 commercial update said volume shipments were expected to begin during the second half of 2026. Management targeted capacity of one million units monthly by late 2027, more than ten times the existing level, and described over ten customer engagements expected to exceed $100 million in combined annual revenue. Those figures are forecasts, not completed sales. They matter because the valuation requires a rapid jump from development work to repeatable production, while the Blazar laser’s scaled deployment remains targeted for 2028.

Lumilens deal and financingA large conditional customer order arrived alongside funding with substantial potential dilution.

In mid-May, Lumilens placed a $50 million initial order within a framework that could exceed $500 million over five years, conditional on development, qualification and manufacturing. POET also raised $400 million by issuing 19.0 million shares plus warrants for another 19.0 million; Lumilens separately received warrants for up to 22.9 million shares, mostly tied to future payments. The stock rose nearly 30% after the customer announcement, then fell 22.4% amid the financing, earnings and a weaker technology market, preventing clean attribution.

Marvell cancels ordersMarvell canceled every inherited Celestial order, exposing customer and disclosure risks.

On April 27, POET said Marvell had canceled all purchase orders inherited through its acquisition of Celestial AI. Marvell cited POET’s alleged disclosure of confidential order and shipping information; POET did not disclose the canceled orders’ value. Another customer’s roughly $5 million order remained active. Reuters reported that the shares fell about 48% following the announcement. The direct timing makes the cancellation the clearest explanation for the reaction, while also demonstrating how fragile early customer commitments can be.

Loading local price history

Revenue

2016

2017

2018

2021

2022

2023

2024

2025

Net income

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Free cash flow

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Total cash / debt

CashTotal debt

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Financial statements

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$1.1M	$41,427	$465,777	$552,748	$209,100	—	—	$3.9M	$2.8M	$1.9M	—
Gross profit	—	—	—	—	—	—	—	$2.4M	$1.5M	$915,746	—
Gross margin	—	—	—	—	—	—	—	62.04%	51.94%	49.19%	—
Research & development	$18.1M	$11.3M	$10.1M	$10.7M	$8.2M	$6.6M	$2.1M	$2.3M	$2.0M	$3.2M	$3.5M
Operating expenses	$43.2M	$30.1M	$20.9M	$20.3M	$17.2M	$14.8M	$8.8M	$8.4M	$7.9M	$14.6M	$12.1M
Operating income	−$33.9M	−$23.6M	−$20.4M	−$19.7M	−$15.7M	−$18.2M	−$11.4M	−$8.4M	−$7.9M	−$13.7M	−$12.1M
Operating margin	−3,150.50%	−56,877.97%	−4,381.35%	−3,565.87%	−7,493.59%	—	—	−216.61%	−283.06%	−736.68%	—
EBITDA	−$59.5M	−$54.6M	−$18.3M	−$19.7M	−$14.8M	−$17.5M	−$11.3M	—	—	—	—
EBITDA margin	−5,535.88%	−131,732.82%	−3,923.56%	−3,562.89%	−7,091.69%	—	—	—	—	—	—
Net income	−$63.0M	−$56.7M	−$20.3M	−$21.0M	−$15.7M	−$18.2M	−$6.0M	−$16.3M	−$12.8M	−$13.2M	−$12.1M
Net profit margin	−5,857.78%	−136,857.18%	−4,351.30%	−3,805.84%	−7,493.59%	—	—	−419.80%	−458.04%	−710.34%	—
Basic EPSper basic share	-$0.68	-$0.94	-$0.51	-$0.57	-$0.45	—	-$0.20	-$0.60	-$0.50	-$0.60	-$0.70
Diluted EPSper diluted share	-$0.68	-$0.94	-$0.51	-$0.57	-$0.45	—	-$0.20	-$0.60	-$0.50	-$0.60	-$0.70

Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders

Top 20 reported holders of POET
Holder	Shares held
CloudAlpha Capital Management Limited/Hong Kong	3.86M
RENAISSANCE TECHNOLOGIES LLC	3.47M
IMC-Chicago, LLC	2.71M
GOLDMAN SACHS GROUP INC	2.31M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	1.68M
Elequin Capital, LP	1.64M
NATIONAL BANK OF CANADA /FI/	1.5M
MORGAN STANLEY	1.36M
Trexquant Investment LP	1.26M
CITADEL ADVISORS LLC	1.07M
CANTOR FITZGERALD, L. P.	1.06M
Clear Street Group Inc.	982.27K
JANE STREET GROUP, LLC	800.48K
NOMURA HOLDINGS INC	734.17K
BANK OF MONTREAL /CAN/	665.85K
UBS Group AG	598.95K
Tairen Capital Ltd	540K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	464.41K
Federation des caisses Desjardins du Quebec	413.45K
Paragon Capital Management Ltd	371.22K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026

Buys0$0.00 disclosed value

Sells (SEC code S)0$0.00 disclosed value

No insider transactions transactions were reported in the stored SEC coverage.

Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about POET yet. Start the conversation.

Write the first post

Poet Technologies Inc. (POET)

Financial charts

Financial statements

Owners

Insider buys & sells

Community posts

It’s quiet here.